Literature DB >> 23470847

Spontaneous resolution of genital Chlamydia trachomatis infection in women and protection from reinfection.

William M Geisler1, Shelly Y Lensing, Christen G Press, Edward W Hook.   

Abstract

The natural history of chlamydia is variable and may include persisting asymptomatic infection, complications, or spontaneous resolution before treatment. Reinfection is common. We evaluated whether spontaneous resolution was associated with decreased reinfection in women returning for treatment of a positive chlamydia screening test. At enrollment, participants were tested for chlamydia, treated with azithromycin, and scheduled for a 6-month follow-up visit for repeat testing. Two hundred participants returned 1 to 12 months after treatment. Spontaneous resolution at enrollment was demonstrated in 44 (22.0%). Reinfection at follow-up occurred in 33 (16.5%), being more frequent in those with persisting infection at enrollment versus spontaneous resolution (31 of 156 [19.9%] vs 2 of 44 [4.5%]; P = .016). Adjusting for age, the odds of reinfection was 4 times higher for participants with persisting infection at enrollment (odds ratio 4.0, 95% confidence interval, 1.1-25.6; P = .034). Chlamydia treatment may attenuate protective immunity in some patients.

Entities:  

Keywords:  chlamydia; immunity; recurrence; reinfection; resolution; spontaneous; treatment

Mesh:

Substances:

Year:  2013        PMID: 23470847      PMCID: PMC3654745          DOI: 10.1093/infdis/jit094

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  32 in total

1.  Summary of notifiable diseases--United States, 2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-06-01       Impact factor: 17.586

2.  Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens--a randomized clinical trial.

Authors:  J R Schwebke; A Rompalo; S Taylor; A C Seña; D H Martin; L M Lopez; S Lensing; J Y Lee
Journal:  Clin Infect Dis       Date:  2011-01-15       Impact factor: 9.079

3.  Long-term trends in Chlamydia trachomatis infections and related outcomes in a U.S. managed care population.

Authors:  Delia Scholes; Catherine L Satterwhite; Onchee Yu; David Fine; Hillard Weinstock; Stuart Berman
Journal:  Sex Transm Dis       Date:  2012-02       Impact factor: 2.830

4.  Chlamydia trachomatis trends in the United States among persons 14 to 39 years of age, 1999-2008.

Authors:  S Deblina Datta; Elizabeth Torrone; Deanna Kruszon-Moran; Stuart Berman; Robert Johnson; Catherine L Satterwhite; John Papp; Hillard Weinstock
Journal:  Sex Transm Dis       Date:  2012-02       Impact factor: 2.830

5.  Time to clearance of Chlamydia trachomatis ribosomal RNA in women treated for chlamydial infection.

Authors:  Cybèle A Renault; Dennis M Israelski; Vivian Levy; Bruce K Fujikawa; Timothy A Kellogg; Jeffrey D Klausner
Journal:  Sex Health       Date:  2011-03       Impact factor: 2.706

6.  Sexually transmitted diseases treatment guidelines, 2010.

Authors:  Kimberly A Workowski; Stuart Berman
Journal:  MMWR Recomm Rep       Date:  2010-12-17

7.  Upsurge of chlamydial reinfection in a large Canadian city: an indication of suboptimal chlamydia screening practices?

Authors:  Mélissa Généeux; Pascale Leclerc; Lucie Bédard; Robert Allard
Journal:  Can J Public Health       Date:  2010 Sep-Oct

8.  Performance of the cobas CT/NG test compared to the Aptima AC2 and Viper CTQ/GCQ assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae.

Authors:  Barbara Van Der Pol; Oliver Liesenfeld; James A Williams; Stephanie N Taylor; Rebecca A Lillis; Barbara A Body; Mindy Nye; Carol Eisenhut; Edward W Hook
Journal:  J Clin Microbiol       Date:  2012-04-18       Impact factor: 5.948

9.  Use of home-obtained vaginal swabs to facilitate rescreening for Chlamydia trachomatis infections: two randomized controlled trials.

Authors:  Fujie Xu; Bradley P Stoner; Stephanie N Taylor; Leandro Mena; Lin H Tian; John Papp; Kathleen Hutchins; David H Martin; Lauri E Markowitz
Journal:  Obstet Gynecol       Date:  2011-08       Impact factor: 7.661

10.  Chlamydia public health programs and the epidemiology of pelvic inflammatory disease and ectopic pregnancy.

Authors:  Michael L Rekart; Mark Gilbert; Rafael Meza; Paul H Kim; Michael Chang; Deborah M Money; Robert C Brunham
Journal:  J Infect Dis       Date:  2012-10-24       Impact factor: 5.226

View more
  50 in total

Review 1.  Human and Pathogen Factors Associated with Chlamydia trachomatis-Related Infertility in Women.

Authors:  S Menon; P Timms; J A Allan; K Alexander; L Rombauts; P Horner; M Keltz; J Hocking; W M Huston
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

2.  Characterization of the Horizontal and Vertical Sexual Transmission of Chlamydia Genital Infections in a New Mouse Model.

Authors:  Sukumar Pal; Delia F Tifrea; Luis M de la Maza
Journal:  Infect Immun       Date:  2019-06-20       Impact factor: 3.441

3.  Identification of Chlamydia trachomatis Antigens Recognized by T Cells From Highly Exposed Women Who Limit or Resist Genital Tract Infection.

Authors:  Ali N Russell; Xiaojing Zheng; Catherine M O'Connell; Harold C Wiesenfeld; Sharon L Hillier; Brandie D Taylor; Michelle D Picard; Jessica B Flechtner; Wujuan Zhong; Lauren C Frazer; Toni Darville
Journal:  J Infect Dis       Date:  2016-10-12       Impact factor: 5.226

4.  Nonpathogenic Colonization with Chlamydia in the Gastrointestinal Tract as Oral Vaccination for Inducing Transmucosal Protection.

Authors:  Luying Wang; Cuiming Zhu; Tianyuan Zhang; Qi Tian; Nu Zhang; Sandra Morrison; Richard Morrison; Min Xue; Guangming Zhong
Journal:  Infect Immun       Date:  2018-01-22       Impact factor: 3.441

5.  Microbiological Characteristics of Chlamydia trachomatis and Neisseria gonorrhoeae Infections in South African Women.

Authors:  Jan Henk Dubbink; Dewi J de Waaij; Myrte Bos; Lisette van der Eem; Cécile Bébéar; Nontembeko Mbambazela; Sander Ouburg; Remco P H Peters; Servaas A Morré
Journal:  J Clin Microbiol       Date:  2015-10-28       Impact factor: 5.948

6.  Modeling the transcriptome of genital tract epithelial cells and macrophages in healthy mucosa versus mucosa inflamed by Chlamydia muridarum infection.

Authors:  Raymond M Johnson; Micah S Kerr
Journal:  Pathog Dis       Date:  2015-10-29       Impact factor: 3.166

Review 7.  Update on Chlamydia trachomatis Vaccinology.

Authors:  Luis M de la Maza; Guangming Zhong; Robert C Brunham
Journal:  Clin Vaccine Immunol       Date:  2017-04-05

8.  Cell Intrinsic Factors Modulate the Effects of IFNγ on the Development of Chlamydia trachomatis.

Authors:  Shardulendra Sherchand; Joyce A Ibana; Alison J Quayle; Ashok Aiyar
Journal:  J Bacteriol Parasitol       Date:  2016-07-25

Review 9.  Screening for genital chlamydia infection.

Authors:  Nicola Low; Shelagh Redmond; Anneli Uusküla; Jan van Bergen; Helen Ward; Berit Andersen; Hannelore Götz
Journal:  Cochrane Database Syst Rev       Date:  2016-09-13

10.  B Cell Presentation of Chlamydia Antigen Selects Out Protective CD4γ13 T Cells: Implications for Genital Tract Tissue-Resident Memory Lymphocyte Clusters.

Authors:  Raymond M Johnson; Hong Yu; Norma Olivares Strank; Karuna Karunakaran; Ying Zhu; Robert C Brunham
Journal:  Infect Immun       Date:  2018-01-22       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.